MCARH109 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of Multiple Myeloma
NCT04555551
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
17
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
BIOLOGICAL:
Infusion of MCARH109 T cells
Sponsor
Memorial Sloan Kettering Cancer Center